Young L. Park

Puch'on, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

A multiple ascending dose, phase1b study to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics of lesigercept, a long-acting IgETrap-Fc fusion protein, in participants with atopy or allergic diseases.

A multiple ascending dose, phase1b study to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics of lesigercept, a long-acting IgETrap-Fc fusion protein, in participants with atopy or allergic diseases.

Journal: International immunopharmacology

Published: June 09, 2026

Associations between metabolic syndrome and allergic diseases a nationwide study in Korea and literature review.

Associations between metabolic syndrome and allergic diseases a nationwide study in Korea and literature review.

Journal: Scientific reports

Published: January 21, 2026

A Multi-Center, Open-Label, Single-Arm, Prospective Investigator Initiated Trial to Evaluate the Efficacy and Safety of Alitretinoin in Patients With Chronic Hand Eczema in Real-World Practice (DWALG_P401) and Overview of Korean Studies.

A Multi-Center, Open-Label, Single-Arm, Prospective Investigator Initiated Trial to Evaluate the Efficacy and Safety of Alitretinoin in Patients With Chronic Hand Eczema in Real-World Practice (DWALG_P401) and Overview of Korean Studies.

Journal: Annals of dermatology

Published: December 23, 2025

2023 Consensus Korean Diagnostic Criteria for Atopic Dermatitis.

2023 Consensus Korean Diagnostic Criteria for Atopic Dermatitis.

Journal: Annals of dermatology

Published: May 06, 2024

Phase 1/2 trials of human bone marrow-derived clonal mesenchymal stem cells for treatment of adults with moderate to severe atopic dermatitis.

Phase 1/2 trials of human bone marrow-derived clonal mesenchymal stem cells for treatment of adults with moderate to severe atopic dermatitis.

Journal: The Journal of allergy and clinical immunology

Published: January 18, 2024

Factors Associated With Achieving Complete Skin Clearance Compared to Almost Complete Skin Clearance in Patients With Moderate to Severe Psoriasis Treated With Biologics: A Retrospective Chart Review.

Factors Associated With Achieving Complete Skin Clearance Compared to Almost Complete Skin Clearance in Patients With Moderate to Severe Psoriasis Treated With Biologics: A Retrospective Chart Review.

Journal: Annals of dermatology

Published: July 30, 2023

Erratum: Assessment of Disease Severity and Quality of Life in Patients with Atopic Dermatitis from South Korea.

Erratum: Assessment of Disease Severity and Quality of Life in Patients with Atopic Dermatitis from South Korea.

Journal: Annals of dermatology

Published: February 07, 2023

Pigmented contact dermatitis and hair dyes: A retrospective case-control multicentre study in Korea.

Pigmented contact dermatitis and hair dyes: A retrospective case-control multicentre study in Korea.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: November 13, 2022

Assessment of Disease Severity and Quality of Life in Patients with Atopic Dermatitis from South Korea.

Assessment of Disease Severity and Quality of Life in Patients with Atopic Dermatitis from South Korea.

Journal: Annals of dermatology

Published: March 21, 2022

Relationships of Serum Homocysteine, Vitamin B12, and Folic Acid Levels with Papulopustular Rosacea Severity: A Case-Control Study.

Relationships of Serum Homocysteine, Vitamin B12, and Folic Acid Levels with Papulopustular Rosacea Severity: A Case-Control Study.

Journal: BioMed research international

Published: February 07, 2022

Two Cases of Delayed Bullous Local Reactions to the ChAdOx1 Adenovirus Vector Vaccine against SARS-CoV-2.

Two Cases of Delayed Bullous Local Reactions to the ChAdOx1 Adenovirus Vector Vaccine against SARS-CoV-2.

Journal: Annals of dermatology

Published: October 08, 2021

Real-World Experience of Long-Term Dupilumab Treatment for Atopic Dermatitis in Korea.

Real-World Experience of Long-Term Dupilumab Treatment for Atopic Dermatitis in Korea.

Journal: Annals of dermatology

Published: September 13, 2021

Showing 1-12 of 48

Last Updated: 09/26/2026